Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131634 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT04131634 is a Phase 2 study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT04131634, a Phase 2 study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
To evaluate the benefit of SAbR for oligo-progressive metastatic urothelial cancer.
Interventions
- RADIATION Stereotactic Ablative Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2021-06-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04131634
The ClinicalTrials.gov registry entry for NCT04131634 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Ablative Radiation is the first listed.
NCT04131634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04131634 about?
NCT04131634 is a clinical study titled "Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer". To evaluate the benefit of SAbR for oligo-progressive metastatic urothelial cancer.
What is the current status of trial NCT04131634?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2020-01-16. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT04131634?
The interventions under investigation include: Stereotactic Ablative Radiation (RADIATION).
Who is sponsoring clinical trial NCT04131634?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.